A prospective randomized study on the risk of bleeding according to the timing of P2Y12 inhibitor resumption after endoscopic colorectal polypectomy
- Conditions
- Neoplasms
- Registration Number
- KCT0008617
- Lead Sponsor
- Yonsei University Yongin Severance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 166
1) Patients aged 19 years or older
2) Patients taking single or dual antiplatelet drugs
i) Those taking a single P2Y12 inhibitor
ii) Those taking both P2Y12 inhibitor + Aspirin
3) Patients who need endoscopic resection (mucosal resection, cold snare polypectomy) for colon neoplasia
i) < 20 mm size polyp
ii) Less than 10 polyps
4) Patients who stopped taking P2Y12 inhibitor for more than 5 days before colonoscopy
1) Patients under the age of 18
2) Those with a history of massive bleeding and hemostasis disorders
3) Cases diagnosed with acute coronary syndrome within 3 months
4) Cases where endoscopy cannot be performed due to unconsciousness or anatomical reasons
5) If consent cannot be obtained
6) Others who are judged by the
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Endpoints and Methods: To compare the incidence of delayed bleeding after endoscopic polypectomy
- Secondary Outcome Measures
Name Time Method Secondary endpoints and methods: Immediate bleeding and cardiovascular stability after endoscopic resection are evaluated.